As alternative PBM models seek to up-end a payer’s longstanding relationship with a large PBM, they must be prepared to ...

Amid growing legislative pressures and industry debates, pharmacy benefit managers (PBMs) are exploring new strategies to ...

Co-production deals with adalimumab biosimilar manufacturers and PBMs have increased biosimilar adoption, but this ...

The FTC has paused its antitrust case against major PBMs, citing a lack of commissioners. The lawsuit alleges unfair ...

The Federal Trade Commission has paused an enforcement action alleging pharmacy benefit managers used illegal rebate programs ...

The Federal Trade Commission late Tuesday stayed a lawsuit accusing pharmacy middlemen of gaming the system to inflate the price of insulin — a drug millions of Americans need to survive. When it did, ...

The Federal Trade Commission’s lawsuit against three large pharmacy-benefit managers over insulin prices is on hold after ...

A bill that passed the House Health Committee on Tuesday could affect how much you pay for prescriptions. But what that ...

A bill designed to force PBMs to pay higher fees to independent drugstores sailed through the state House, but lobbyists are ...

The Alabama Legislature moved another step closer to approving a measure to pay pharmacists a $10 dispensing fee for each ...